METHOD AND KIT FOR DIAGNOSIS OF HORMONAL SKIN AGING
    3.
    发明申请
    METHOD AND KIT FOR DIAGNOSIS OF HORMONAL SKIN AGING 审中-公开
    用于诊断激素皮肤老化的方法和试剂盒

    公开(公告)号:WO2009048282A3

    公开(公告)日:2009-09-17

    申请号:PCT/KR2008005945

    申请日:2008-10-09

    Abstract: Disclosed are a kit for diagnosing skin aging using one or more polynucleotides or their complementary polynucleotides that hybridize with a gene sequence, a pair of primers for the gene sequence; or one or more monoclonal antibodies binding to the polypeptide encoded by the gene, which are used to identify the genes of which the expression pattern is changed in a skin keratin-forming cell by female hormone and used to diagnose degree of skin aging caused by female hormonal deficiency by using the information, and a method using the same.

    Abstract translation: 公开了一种用于诊断皮肤老化的试剂盒,其使用与基因序列,基因序列的一对引物杂交的一种或多种多核苷酸或它们的互补多核苷酸; 或与由该基因编码的多肽结合的一种或多种单克隆抗体,其用于鉴定表达模式在皮肤角质形成细胞中由雌激素改变的基因,并用于诊断由雌性引起的皮肤老化程度 使用该信息的激素缺乏症以及使用该信息的方法。

    Method for diagnosis of abnormal keratinization
    4.
    发明公开
    Method for diagnosis of abnormal keratinization 有权
    用于诊断异常KERA化的方法

    公开(公告)号:KR20120103537A

    公开(公告)日:2012-09-19

    申请号:KR20120098405

    申请日:2012-09-05

    Abstract: PURPOSE: A method for screening an agent for preventing aberrant keratinocyte differentiation is provided to use a gene as a gene target for developing a therapeutic agent for treating dermatitis and to evaluate the agent. CONSTITUTION: A method for screening an agent for preventing aberrant keratinocyte differentiation comprises: a step of transfection of plasmids to cells; a step of treating the cell to a test compound; and a step of identifying whether the test compound stimulates the reporter gene. The plasmids includes: a plasmid containing Nrf-2 gene and universal promoter; a plasmid contains DNA which binds with a transcription factor and a reporter gene; and a plasmid containing Nkx-2.5, AP-1, MEIS1A/HOXA9, MEIS1B/HOXA9, CREB, ISRE-BP, Hand1/E47, Pax-6, c-Myb, v-Maf, Elk-1, E47, CRE-BP1, IRF-1, IRF-2, c-Rel, c-Ets-1(p54), USF, VBP, Hox-1.3, Brn-2, COMP1-factor, CDP_CR1, CP2 or NF-kB(p50) gene and a universal promoter. The agent is a therapeutic agent for treating psoriasis. [Reference numerals] (AA) Gene pattern in which expression is reduced during differentiation; (BB) Relative expression level(times); (CC) Time(days)

    Abstract translation: 目的:提供一种筛选用于预防异常角化细胞分化的药剂的方法,以使用基因作为开发用于治疗皮炎的治疗剂的基因靶标并评价该药物。 构成:筛选用于预防异常角化细胞分化的药剂的方法包括:将质粒转染至细胞的步骤; 将细胞处理成测试化合物的步骤; 以及鉴定测试化合物是否刺激报道基因的步骤。 质粒包括:含有Nrf-2基因和通用启动子的质粒; 质粒含有与转录因子和报告基因结合的DNA; 和含有Nkx-2.5,AP-1,MEIS1A / HOXA9,MEIS1B / HOXA9,CREB,ISRE-BP,Hand1 / E47,Pax-6,c-Myb,v-Maf,Elk-1,E47,CRE- BP1,IRF-1,IRF-2,c-Rel,c-Ets-1(p54),USF,VBP,Hox-1.3,Brn-2,COMP1因子,CDP_CR1,CP2或NF-kB(p50) 和通用启动子。 该药剂是治疗牛皮癣的治疗剂。 (AA)分化期间表达降低的基因模式; (BB)相对表达水平(次); (CC)时间(天)

Patent Agency Ranking